Research ReportsPharma, Healthcare Q2 Earnings Preview: Improved Margin In Most Cases With Few Exceptions: Yes Securities
ADVERTISEMENT
Pharma, Healthcare Q2 Earnings Preview: Improved Margin In Most Cases With Few Exceptions: Yes Securities
The brokerage reckons Ajanta, JB Chemical and Torrent Pharma could report better than expected numbers while Syngene and Gland could display weaker set of earnings.
Colourful capsules arranged for photograph. (Source: pxhere.com)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.